How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Webcast
UDI Value in Recall Management
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r
Webcast
The Secrets of Successful Collaboration: Part 4
AHRMM presents a four-part series on successful collaboration with suppliers.
Book
The Healthcare Supply Chain: Best Practices for Operating at the Intersection of Cost, Quality, and Outcomes
This book was written to enhance the strategic contributions of the healthcare supply chain in a way that is most meaningful to hospitals’ an
White Papers
AHRMM19 CQO Summit White Paper | CQO: The Power of Clinical Integration
AHRMM19 CQO Summit White Paper entitled CQO: The Power of Clinical Integration.
Webcast
Value Based Purchasing and Value Analysis 101 – Part 3
Howard Mann, vice president, supply chain management at Cardiovascular Care Group discusses the basics of value analysis and value based purchasing
On-Demand Educational Webinars
The Impact of Supply Chain Processes on O.R. Time, Efficiency, & Overall Cost
Resiliency in the operating room is imperative in today’s health care climate. A well-functioning OR has the potential to increase the number of…